Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Anesthesiology
2015 Feb 01;1222:325-33. doi: 10.1097/ALN.0000000000000505.
Show Gene links
Show Anatomy links
Discovery of a novel general anesthetic chemotype using high-throughput screening.
McKinstry-Wu AR
,
Bu W
,
Rai G
,
Lea WA
,
Weiser BP
,
Liang DF
,
Simeonov A
,
Jadhav A
,
Maloney DJ
,
Eckenhoff RG
.
???displayArticle.abstract???
The development of novel anesthetics has historically been a process of combined serendipity and empiricism, with most recent new anesthetics developed via modification of existing anesthetic structures. Using a novel high-throughput screen employing the fluorescent anesthetic 1-aminoanthracene and apoferritin as a surrogate for on-pathway anesthetic protein target(s), we screened a 350,000 compound library for competition with 1-aminoanthracene-apoferritin binding. Hit compounds meeting structural criteria had their binding affinities for apoferritin quantified with isothermal titration calorimetry and were tested for γ-aminobutyric acid type A receptor binding using a flunitrazepam binding assay. Chemotypes with a strong presence in the top 700 and exhibiting activity via isothermal titration calorimetry were selected for medicinal chemistry optimization including testing for anesthetic potency and toxicity in an in vivo Xenopus laevis tadpole assay. Compounds with low toxicity and high potency were tested for anesthetic potency in mice. From an initial chemical library of more than 350,000 compounds, we identified 2,600 compounds that potently inhibited 1-aminoanthracene binding to apoferritin. A subset of compounds chosen by structural criteria (700) was successfully reconfirmed using the initial assay. Based on a strong presence in both the initial and secondary screens the 6-phenylpyridazin-3(2H)-one chemotype was assessed for anesthetic activity in tadpoles. Medicinal chemistry efforts identified four compounds with high potency and low toxicity in tadpoles, two were found to be effective novel anesthetics in mice. The authors demonstrate the first use of a high-throughput screen to successfully identify a novel anesthetic chemotype and show mammalian anesthetic activity for members of that chemotype.
Brambrink,
Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain.
2010, Pubmed
Brambrink,
Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain.
2010,
Pubmed
Brannigan,
Multiple binding sites for the general anesthetic isoflurane identified in the nicotinic acetylcholine receptor transmembrane domain.
2010,
Pubmed
Bu,
Ferritin couples iron and fatty acid metabolism.
2012,
Pubmed
Butts,
Identification of a fluorescent general anesthetic, 1-aminoanthracene.
2009,
Pubmed
,
Xenbase
Chiara,
Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.
2013,
Pubmed
Ebalunode,
Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds.
2009,
Pubmed
Eckenhoff,
Molecular interactions between inhaled anesthetics and proteins.
1997,
Pubmed
Eckenhoff,
Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity.
2004,
Pubmed
Heusser,
Functional validation of virtual screening for novel agents with general anesthetic action at ligand-gated ion channels.
2013,
Pubmed
,
Xenbase
Hopkins,
Ligand efficiency: a useful metric for lead selection.
2004,
Pubmed
Ikonomidou,
Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.
1999,
Pubmed
Inglese,
Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.
2006,
Pubmed
Jenkins,
Evidence for a common binding cavity for three general anesthetics within the GABAA receptor.
2001,
Pubmed
Kokel,
Using the zebrafish photomotor response for psychotropic drug screening.
2011,
Pubmed
Krasowski,
General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility.
2001,
Pubmed
,
Xenbase
Lea,
A high-throughput approach for identification of novel general anesthetics.
2009,
Pubmed
Li,
Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog.
2006,
Pubmed
Linden,
The in vivo contributions of TASK-1-containing channels to the actions of inhalation anesthetics, the alpha(2) adrenergic sedative dexmedetomidine, and cannabinoid agonists.
2006,
Pubmed
Mihic,
Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors.
1997,
Pubmed
,
Xenbase
Peterson,
Designing zebrafish chemical screens.
2011,
Pubmed
Rai,
Discovery of Novel General Anesthetics Using Apoferritin as a Surrogate System
2010,
Pubmed
Reynolds,
Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms.
2003,
Pubmed
Vedula,
A unitary anesthetic binding site at high resolution.
2009,
Pubmed
Wang,
A grid algorithm for high throughput fitting of dose-response curve data.
2010,
Pubmed
Weiser,
An estimation of the global volume of surgery: a modelling strategy based on available data.
2008,
Pubmed
Wong,
Modulation of [3H]diazepam binding in rat cortical membranes by GABAA agonists.
1985,
Pubmed
Xie,
The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation.
2007,
Pubmed
Yasgar,
Compound Management for Quantitative High-Throughput Screening.
2008,
Pubmed
